drugset / Trial / NCT04190004
Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia
RandomizedCrossoverDouble-blindOther
Summary
The study investigates the effect of 40IU of intranasal vasopressin on cooperative behavior in patients with schizophrenia
Timeline
- Start
- 2018-01-01
- Primary completion
- 2018-11-30
- Completion
- 2018-11-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vasopressin | Peptide | 40 iu | Intranasal |